6 курс / Кардиология / Ишемическая_болезнь_сердца_Распространенность,_профилактика,_адаптация

течение 2-х десятилетий и в период социально-экономического кризиса в России / В.В. Гафаров, В.А. Пак, И.В. Гагулин, А.В. Гафарова. - Новосибирск, 2000. - 284 с.

223.Эпидемиология и профилактика хронических неинфекционных заболеваний в течение 2-х десятилетий и в период социально-экономического кризиса в России: монография / В.В. Гафаров, В.А. Пак, И.В. Гагулин и др. // Новосибирск, 2000. - 282 с.

224.Эпидемиология и факторы риска ишемической болезни сердца / под ред. А.Н. Климова. - Л.: Медицина,1989.- 176 с.

225.Эпидемиология ишемической болезни сердца и ее связь с основными факторами риска среди мужского населения в некоторых городах СССР (кооперативное исследование) / Константинов В.В., Жуковский Г.С., Шестов Д.Б., Малахов В.Н.

и др. // Терапевт. архив. - 1991.- Т.63.- № 1.- – С. 11-16.

226.Эпидемиология факторов риска ишемической болезни сердца в открытой популяции Тюмени./ Л.В. Драчева, Е.В. Акимова, В.В. Гафаров, В.А. Кузнецов // Сборник тезисов РНКК «Российская кардиология: от центра к регионам» ТОМСК, 2004. Приложение 2 к журналу «Кардиоваскулярная терапия и профилактика», 2004. – № 4. – С.150.

227.Юнакова, И.А.Изучение особенностей причин смертности на примере исследования, проведенного в Томске / И.А. Юнакова, И.Н. Конобеевская, Р.С. Карпов // Актуальные вопросы эпидемиологии сердечно-сосудистых заболеваний и организации кардиологической помощи населению. Сб. тез.докладов Всероссийской научно-практической конференции. – Кемерово, 2003. – С. 87.

228.Яковлев, В. А. Ишемическая болезнь сердца (факторы риска и профилактика / В. А. Яковлев, А. И. Чепель // Новые С.-Петербургские ведомости. – 2003. – № 2. –

С. 22–27.

229.Янченко О.В., Воевода М.И. Особенности распространенности факторов риска сердечно-сосудистых заболеваний и их ассоциации с инфарктом миокарда у коренных мужчин республики Хакасия // Материалы межрегиональной научнопрактической конференции «Актуальные проблемы медицины». - Абакан.-2007.–

С.111-112.

230.Яскевич, Р.А. Соотношение основных факторов риска сердечно-сосудистых заболеваний с показателями углеводного обмена у больных артериальной гипертонией /Р.А. Яскевич, И.И. Хамнагадаев, Л.С. Поликарпов, В.И. Мандрык // Российская научная конференция с международным участием “Север – человек: проблемы сохранения здоровья ”: Тез. Докл. научн. конф. – Красноярск. - 2001. -

С. 222-223.

231.Acute and reversible cardiomyopathy provoked by stress in women from the United States / S.W. Sharkey, J.R. Lesser, A.G. Zenovich et al. // Circulation.- 2005.- V. 111.- P. 472-479.

232.Admissions for myocardial infarction and World Cup football: database survey / D. Carroll, S. Ebrahim, K.Tilling et al. // BMJ. - 2002. - V. 88 - P. 1439-1442.

233.AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update. / S.C. Jr. Smith, J. Allen., S.N. Blair et al. // J. Am. Coll. Cardiol. – 200. - V.47. – P. 2130-2139.

234.Albert, M.A. Alcohol consumption and plasma concentration of C-reactive protein/ M.A. Albert // Circulation. - 2003. - V.107. - P.443.

235.Alcohol consumption and risk of dementia: the Rotterdam Study / A. Ruitenberg, J.C. van Swieten, J.C.M. Witteman et al. // Lancet. – 2002. – V. 359. – P. 281−286.

236.Alpert, J.S. Cardiovascular diseases / J.S. Alpert // J. Amer. Med. Assoo. - 1985. -

- 200 -

V.254, N.16. - P.2264-2267.

237.Alpert, M.A. Obesity and the heart / M.A. Alpert, M.W. Hashimi // Am. J. Med. Sci. - 1993.-V. 306.-P. 117-123.

238.American Diabetes Association. Standards of Medical Care in Diabetes: Dislipidemia Management. Diabetes Care. - 2007. - V. 30. - P. S4–S41.

239.Anderson, KM. Cholesterol and mortality. 30 years of follow-up from the Framingham study/K.M. Anderson, W.P.Castelli, D.Levy // JAMA.- 1987.- V.257.- P.2176-2180 240.Angiotensin converting enzyme gene deletion allele is independently and strongly

associated with coronary atherosclerosis and myocardial infaretion / E. Arbustiuni, M. Grasso, R. Fazani et al. // Br. Heart J. – 1995. – V. 74. - P. 584—591.

241.Arterial hypertension in Mexico: results of the National Health Survey 2000 /O.V. Monroy, M. R. Peralta, A. L. Esqueda et al. // Arch. Cardiol. Mex. - 2002. - V. 72. - P.71-84.

242.Arterial hypertension in the French Caribbean regions: gender related differences /J. Inamo, S. Malfatti, T. Lang et al. //Arch. Mal. Coeur Vaiss. - 2005. - V.98, N7-8. - P.845-849.

243.Associated factors to total cholesterol: school based study in southern Brazil /M.L. Bergmann, G.G. Bergmann, R. Halpern et all. /Arq. Bras. Cardiol. 2011. - V. 96. - P.1- 68.

244.Associated variables to hypertension in a region of Argentina / H.A. Carbajal, M.R. Salazar, B. Riondet et al. // Medicina (B. Aires). - 2001. - V. 61. - P.801-809.

245.Association of the platelet PlA polymorphism of glycoprotein IIb/IIIa and the fibrinogene Bβ 448 polymorphism with myocardial infarction and extent of coronary artery disease / A.M. Carter, N. Ossei-Gerning, I.J. Wilson et al. // Circulation. - 1997. - V. 96. - P. 1424–1431.

246.Atherosclerosis in Alaska Natives and non-natives / W.P. Newman, J.P. Middaugh, M.T. Propst, D.R. Rogers // Lancet. – 1993. - V. 24. (341). - P.1056-1057.

247.Auerbach, O. Smoking in relation to atherosclerosis of the coronary arteries / O. Auerbach, E.C. Hammond, L. Garfinkel //New Engl. J. Med.-1965.- V.273.-P.161-174.

248.Barbir, М. High prevalence of hypertriglyceridaemia and apolipoprotein abnormalities in coronary artery disease / M. Barbir, D. Wile, I. Trayner // Br. Heart J. - 1988. - V. 60. - P. 397 - 403.

249.Barnoya, J. Cardiovascular effects of secondhand smoke nearly as larg as smoking / J. Barnoya, S.A. Glantz // Circulation. - 2005. - V. 111. -P. 2684-2698.

250.Bazzano, L.A. Dietary intake of fruits and vegetables and risk of cardiovascular disease / L.A. Bazzano, M.K. Serdula, S. Liu // Curr. Atheroscler. Rep. – 2003. - N 5(6). – P. 492-499.

251.Beekman, A.T. Depression and cardiac mortality / A.T. Beekman, A. Honig // Arch. Gen. Psychiatry. - 2001. - V. 58 (3). - P. 221-227.

252.Behar, S. Lowering fibrinogen levels: clinical update. BIP Study Group. Beza-fibrate Infarction Prevention / S. Behar // Blood Coagul Fibrinolysis 1999. - 10 Suppl 1. - P. 41 - 43.

253.Bello, N. Epidemiology of coronary heart disease in women / N. Bello, L. Mosca // Prog. Cardiovasc Dis. - 2004. - V. 46, N 4.- P. 287-295.

254.Body fat distribution and risk of coronary heart disease in men and women in the European Prospective Investigation Into Cancer and Nutrition in Norfolk cohort: a population-based prospective study / D. Canoy, S.M. Boekholdt, N. Wareham et al. /Circulation. – 2007. – V. 116 – P. 2933-2943.

255.Bohman, M. Maternal inheritance of alcohol abuse. Cross-fostering analysis of adopted women /M. Bohman, S. Sigvardsson, R. Cloninger // Arch. Gen. Psychiatry. – 1981. –

- 201 -

V. 38. – P. 965-969.

256.Borhani, N. Report of a 10 years UP study of the San Francisco longs-horemen. Mortality from coronary heart disease and from all causes / N. Borhani, H. Hechter, K. Breslow // Cyron. Dis. - 1963.-V. 16.-P. 1251-1265.

257.Boscarino, J.A. Electrocardiogram abnormalities among men with stress-related psychiatric disordes: implications for coronary heart disease and clinical research / J.A. Boscarino, J. Chang // Ann. Behav. Med. - 1999. - V. 21 - P. 227-234.

258.Bush, D.E. Even minimal symptoms of depression increase mortality risk after acute myocardial infarction / D.E. Bush, R.S. Ziegelstein, M. Tayback // Am. J. Cardiol. - 2001. - V. 88 (4). - P. 337-341.

259.Calculation of coronary risk in the 35-60 year old population registered at a health centre / E. Armero Garrigos, F. Viribay Lorite, A. Cabal Garcia et al. // Aten / Primaria.

– 2003. – V. - 32.- N 10.- P. 577-582.

260.Cardiovascular complications of obesity. / T. Cascella, F. Giallauria, D. Tafuri et al. // Monaldi Arch. Chest Dis. - 2006. - V.66. - N 4. – P. 270-274.

261.Cardiovascular disease prevention and care in Latino and Hispanic subjects. / J.A. Davidson, P.R. Moreno, J.J. Badimon, et al. // Endocr. Pract. - 2007. - V.13.- N 1.- P.77-85.

262.Cardiovascular Risk Factors et Coronary Mortality. 15-Year Follow-up of Middle-aged Men and men in Eastern Finland / P. Jousilahti, J. Tuomilehto, E.Vartiainen, et al. // Circulation. - 1996. - V. 9. - P. 1372-9.

263.Carlson, L. Risk factors for myocardial infarc¬tion in the Stockholm Prospective Study / L. Carlson, L.E. Bottiger, A. Per-Fric // Acta Med. Scand. - 1979. - V. 206. - N 25. - P. 351-360.

264.Carlson, L.A. Ishamic heart disease in relation to fasting values of plasma trigdlicerides and cholesterol. Stockholm prospective studi / L.A. Carlson, L.E. Bottiger // Lancet. - 1972. - V. 1.- P.865-868

265.Castelli, W.P. The trigliceride issue: a view from Framingham / W.P. Castelli // Am. Heart J. - 1986. - V. 112. - P. 432 - 437.

266.Changes in Smoking Prevalence among U.S. Adults by State and Region: Estimates from the Tobacco Use Supplement to the Current Population Survey, 1992-2007.

267.Childhood social circumstances and psychosocial and behavioural factors as determinants of plasma fibrinogen / E. Brunner, G.D. Smith, M. Marmot // Lancet 1996. - V.347. - P. 1008 -1013.

268.Cholesterol reduction yields clinical benefits: meta-analysis including recent trials /A.L. Gould, G.M. Davies, E. Alemao et al. // Clin. Ther. - 2007.-V.29. - P.778—794.

269.Chronic stress and age-related increases in the proinflammatory cytokine 11-6 / J.K. Kiecolt-Glaser, K.J. Preacher, R.C. MacCallum et al. // Proc. Natl. Acad. Sci. USA. – 2003. – V.100. - P.9090-9095.

270.Cigarette smoking as a risk factor for stroke: the Framingham study / P.A.Wolf, R.B. Agostino, W.B. Kannel et al. // JAMA. – 1988. – V. 259. – P. 1025–1029.

271.Clinical signs of familial hypercholesterolemia in patients with familial defective apolipoprotein B-100 and normal low density lipoprotein receptor function / N.B. Myant, J.J. Gallagher, B.L. Knight et al. // Arterioscler. Thromb. – 1991. - V. 11. – P. 691—703.

272.Cohn B.A. Did early detection and tritment contribute to the decline in ischemic heart disease mortaliti? Prospective evidence from the alameda county study / B.A. Cohn, G.A. Kaplan, R.D. Cohen //Amer.J.Epidemiol.-1988.-V.127.- N 6.- P.1143 -. 1154.

273.Coronary artery disease. Status of preventive effort / J. Stamler, D.M. Berkson, M. Levinson et al. //Arch.Environ. Helth.-1966. - V.13. - P.322-335.

- 202 -

274.Coronary heart disease prevalence and its relation to risk factors in American Indians. The Strong Heart Study / B.V. Howard, E.T. Lee, L.D. Cowan et al. // Am. J. Epidemiol. - 1995. – V.142. - N 3. - P. 254-268.

275.Corrao, J.M. Coronary heart disease risk factors in women /J.M. Corrao, R.C. Becker, I.S. Ockent et al. // Cardiology. - 1990. - V. 77, Suppl. 2. - P. 8-24.

276.Costa e Silva, J.A. Facing depression / J.A. Costa e Silva //AVPA Teaching Bulletin on Depression. 1993. - V. 1. - P. 115.

277.C-reactive protein an independent risk factor for essential hypertension? /L.E. Bautista, P. Lopez-Jaramillo, L.M. Vera et al. //J. Hypertens. - 2001. - V. 19. - P.2107.

278.C-reactive protein and the severity of atherosclerosis in myocardial infarction patients with stable angina pectoris / M.C.Tataru, J. Heinrich, R. Junker et al. // Eurl Heartl J. – 2002. – V. 21. – P. 1000-1008.

279.C-reactive protein, cardiovascular risk, and renal disease in a remote Australian Aboriginal community / S. McDonald, G. Maguire, N. Duarte, X.L. et al. // Clin. Sci. (Lond). - 2004. – V. 106. - N 2. - P. 121-128.

280.Cullen, K. J. Alcohol and mortality in Busselton, Western Australia / K. J.Cullen, M. W. Knulman, N. J. Ward // Am. J. Epidemiology. - 1993.- V.136. - P.242-248.

281.Danish singles have a twofold risk of acute coronary syndrome: data from a cohort of 138 290 persons / К.М. Nielsen, О. Faergeman, M.L. Larsen, et al. // J. Epidemiol Community Health. - 2006. - N60(S). - P.721-728.

282.Das, U.N. Beneficial effect(s) of n-3 fatty acids in cardiovascular diseases: but, why and how? / U.N. Das // Prostaglandins Leukot Essent Fatty Acids. - 2001. – V. 64. - N 1. - P. 74.

283.Davidson, N.O. Apolipoprotein B: mRNA Editing, Lipoprotein Assembly, and Presecretory Degradation / N.O. Davidson, G.S. Shelness // Ann. Rev. Nutr. - 2000. - V. 20. - P.169-193.

284.Death and coronary attacs in men after giving up cigarette smoking. A report from the Framingham study / T. Gordon, W. Kannel, D. Megree et al. // Lancet. – 1974. – V. 2.

– P. 1345–1348.

285.Deletion polymorphism in the angiotensin converting gene is a potent risk factor for myocardial infarction / F. Gambien, O. Poirier, L. Lecerf et al. //Il Nature. - 1992.- V.359- P. 1600-1603.

286.Depression, psychotropic medication, and risk of myocardial infarction: prospective data from the Baltimore EGA follow-up / L.A. Pratt, D.E. Ford, R.M. Crum et al. // Circulation. - 1996. - V. 94. - P. 3123-3129.

287.Dietary omega-3 fatty acids and gestational hypertension in the Inuit / J. Gerrard, D. Popeski, L. Ebbeling et al. // Arctic. Med. Res. – 1991. - P. 763-767

Dietary patterns and cardiovascular disease mortality in Japan: a prospective cohort study / T. Shimazu, S. Kuriyama, A. Hozawa et al. // Int. J. Epidemiol. 2007. - V 36. – P. 600– 609.

289.Different metabolic predictors of whitecoat and sustained hypertension over a 20-year follow-up period: a population-based study of elderly men / K. Bjorklund, L. Lind, B. Vessby et al. // Circulation. - 2002. - V. 106, N 1. - P. 63-68.

290.Dilaveris, P.E. Inadequate blood pressure control in a 'low risk' Mediterranean population / P.E. Dilaveris, D.J. Richter, J.E. Gialafos // Eur. Heart J. - 1999. - V.20. - P. 1845.

291.Doll, R. Mortality in relation to smoking: 50 years’ observations on male British doctors / R. Doll, R. Peto, J. Boreham // BMJ. – 2004. – V. 328. – P. 1519.

292.Durrington, P.N. Paraoxonase and Atherosclerosis / P.N. Durrington, B. Mackness, M.I. Mackness // Arterioscler. Throm. Vasc. Biol. - 2001. - V. 21. - P. 473–480.

- 203 -

293.Dyerberg J. Coronary heart disease in Greenland Inuit: a paradox. Implications for western diet patterns. / J. Dyerberg // Arctic Med. Res. - 1989. V. 48.- N 2.- P.47-54 294.Early-life and adult socioeconomic status and inflammatory risk markers in adulthood /

R.A. Pollitt, J.S. Kaufman, K.M. Rose // Eur. J. Epidemiol. – 2007. – V. 22. - N 1. - P. 55-66.

295.Echocardiographic dimensions in athletes in relation to their training programs./ L.H. Snoeckx, H.F. Abeling, J.A. Lambregts et al. // Medicine and Science in Sports and Exercise.- 1982.-V. 14.-P. 428-434.

296.Effect of ramipril on morbidity end mode of death among survivors of acute myocardial infarction with clinical evidence of heart fairure. A report the AIRE study investigates / J.G. Cleland, L. Erhardt, G. Murray et al. // Eur. Heart. J. - 1997. – P.41 - 51.

297.Effect of Smoking on Arterial Stiffness and Pulse Pressure Amplification / A. Mahmud, J. Feely // J. Hypertension. - 2003. - V. 41. - P. 183.

298.Effects of cigarette smoking at rest and during exercise. II. Role of venous return / R.J. Krone, A.N. Goldbarg, M. Balkoura et al. // J. Appl. Physiol. – 1972. - V. 32,N 5. - P. 745-748.

299.Effects of daily alcohol intake on the blood pressure differ depending on an individual's sensitivity to alcohol: oriental flushing as a sign to stop drinking for health reasons / T. Itoh, M. Matsumoto, M. Nakamura et al. // Hypertension. – 1997. – V. 15 (11). - P.1211–7.

300.Ellis J.L. Cardiovascular disease risk factors in native Americans: a literature review / J.L. Ellis, D. Campos-Outcalt // Am. J. Prev. Med. - 1994. - N 10. - P.295-307

301.Epidemiology of low cholesterol levels in older adults: the Cardiovascular Health Study / T.A. Manolio, W.H. Ettinger, R.P. Tracy et al. // Circulation. - 1993. -V. 87.-P. 728-737.

302.Epstein, F.H. Lessons from falling coronary heart disease mortality in the United States / F.H. Epstein // Postgrad. Med. J. - 1984. - V. 60. - P. 15-19.

303.Ernst, E. Fibrinogen as a cardiovascular risk factor: a meta-analysis and review of the literature / E. Ernst, K.L. Resch // Ann. Intern. Med. 1993. V.118. - P. 956 - 963.

304.Ernst, E. Therapeutic interventions to lower plasma fibrinogen concentration / E. Ernst, K.L. Resch // Eur. Heart. J. – 1995. - 16 Suppl A: P. 47 - 53.

305.European guidelines on cardiovascular disease prevention in clinical practice: fourth joint task force of the European Society of cardiology and other societies / I. Graham, D. Atar , K. Borch-Johnsen et al. // Eur. J. Cardiovasc. Prev. Rehabil. - 2007. - V.14. - P.S1-S113.

306.EURopean trial On reduction of cardiacevents with Perindopril in stable coronary Artery disease Investigators. Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study) // Lancet. - 2003.- V. 362.- P. 782-788.

307.Fagard, R.H. Exercise characteristics and blood pressure response to dinamic physical training /R.H. Fagard // Med. Sci. Sport Exerc. - 2001. - V.33, N6.- P. 484-492.

308.Fibrinogen and factor VII in the prediction of coronary risk. Results from the PROCAM study in healthy men / J. Heinrich, L. Balleisen, H. Schulte et al. // Arterioscler. Thromb. - 1994. – V. 14. – P. 54 - 59.

309.Fibrinogen and risk of cardiovascular disease / W.B. Kannel, P.A. Wolf, W.P. Castelli, R.B. D'Agostino // JAMA. - 1987. – V. 258. – P. 1183 - 1186.

310.Fibrinogen in relation to personal history of prevalent hypertension, diabetes, stroke, intermittent claudication, coronary heart disease, and family history: the Scottish Heart

- 204 -

Health Study / A.J. Lee, G.D. Lowe, M. Woodward, H. Tunstall-Pedoe // Br. Heart J.- 1993. – V. 69. - P. 338 - 342.

311.Folkow, B. Mental stress and its importance for cardiovascular disorders; physiological aspects, "from-mice-to-man"/ B. Folkow // Scand. Cardiovasc. J. - 2001.-V. 35.-P. 16372.

312.For the Systolic Hypertension in Europe/ J.A. Staessen, L. Thijs, R. Fagard et al. // Hypertension. - 1994. - V. 24. - P. 793–801.

313.Fredrickson, D.S. Fat transport in lipoproteins - an integrated approach to mechanisms and disorders / D.S. Fredrickson, R.I. Levy, R.S. Lees // N. Engl. J. Med. – 1967. – V. 276. – P. 34-44.

314.Frequency of fruit and vegetable consumption and coronary heart disease in France and Northern Ireland: the PRIME study / L. Dauchet, J. Ferrieres, D. Arveiler, et all. // Br. J. Nutr. - 2004. - V. 92(6). - P. 963-972.

315.Galloway, J.M. The epidemiology of atherosclerosis and its risk factors among Native Americans / J.M. Galloway // Curr. Diab. Rep. - 2002. - N 2(3): - P. 274-281.

316.Gender differences in prevalence, risk, and clinical correlates of alcoholism comorbidity in bipolar disorder / M. A. Frye, L.L. Altshuler, S.L. Mc Elroy et al. // Am. J. Psychiatry. - 2003. - V.160. - P. 883 -889.

317.Gender, depression, and one-year prognosis after myocardial infarction / N. FrasureSmith, F. Lesperance, M. Juneau et al. // Psychosom Med. -1999.-V.61.-P.26-37.

318.Genetic associations with human longevity at the APOE and ACE loci / F. Schachter, L. Faure-Delanef, F. Guenot et al. // Nature Genet. - 1994. – V.6. - P.29-32.

319.Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data / A.D. Lopez, C.D. Mathers, M. Ezzati et al. // Lancet. – 2006. – V. 367. – P. 1747–1757,

320.Goodwin D.W. Is alcoholism hereditary? 2-nd Ed / D.W. Goodwin // N.Y.: Ballantine books, 1988. – 260 p.

321.Goodwin D.W. Studies of familial alcoholism: A review / D.W. Goodwin // J. Clin. Psychiatr. - 1984. - V.45. - P. 14-17.

322.Gopdon, T. Higt density lipoproteins as a protective factor against coronary heart desease / T. Gopdon, W.P. Castelli, M. Hjortland, et al. // The Framingham Study. // Am. J. Med. - 1977. - V. 62. - P.707-714.

323.Gould, K.L. New concepts and paradigms in cardiovascular medicine: the non-invasive management of coronary artery disease / K.L. Gould // Am. J. Med. - 1998. - V. 104. - P. 2-17.

324.Guidelines for the Management of Arterial Hypertension The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) // Journal of Hypertension. - 2007. – V. 25. - N 6. - P.1105-1120

325.Gus, I. Prevalence of risk factors for coronary artery disease in the Brazilian State of Rio Grande do Sul / I. Gus, A. Fischmann, C. Medina // Arq. Bras. Cardiol. - 2002. - V. 78. - P.478-490.

326.Hajjar, I. Trends in prevalence, awareness, treatment and control of hypertension in the United States, 1988–2000 / I. Hajjar, T.A. Kotchen // JAMA. - 2003. - V. 290. - P.199– 206.

327.Harjai, K.J. Potential new cardiovascular risk factors: left ventricular hypertrophy, homocysteine, lipoprotein(a), triglycerides, oxidative stress, and fibrinogen / K.J. Harjai // Ann. Intern. Med. – 1999. – V.131. - P. 376 - 386.

328.Hatahet W. Prevalence of risk factors to coronary heart disease in an Arab-American population in southeast Michigan / W. Hatahet, P. Khosla, T.V. Fungwe // Int. J. Food

- 205 -

Sci. Nutr. - 2002. - V.53. - N 4. - P. - 325-335.

329.Hbejan, K. Smoking effect on ischemic heart disease in young patients. / K. Hbejan // Heart Views. - 2011. - V.12. - P.1-6.

330.Heart disease in Native Americans / J.S.Alpert, R.Golberg, I.S.Ockene, P.Taylor // Cardiology. - 1991. - V.78, N 1. - P.3-12.

331.Hemostatic factors in Australian Aboriginal and Torres Strait Islander populations / Z. Wang, K. Rowley, J. Best et al. // Metabolism. 2007. - V. 56. - N 5. - P. 629-635.

332.Higgins, M. Patients, families and populations at high risk for coronary heart disease / M. Higgins // Eur. Heart J. - 2001. - V. 22. - P. 1682-1690.

333.Hoffman, A. Elevated blood pressure in schoolchildren related to higt sodium levels of the drinking water / A. Hoffman, G.J. Waandrager, H.A. Valkeuburg // CVD Epidemiol. News Letter. - 1980. - P .29-86.

334.Homocysteine, vitamin status and risk of vascular disease / P. Verhoef, R. Meleady, L.E. Daly et al. // Eur. Heart J. - 1999. - V. 20. - P. 1234-1244.

335.Horrobin, D.F. Low prevalences of coronary heart disease (CHD), psoriasis, asthma and rheumatoid arthritis in Eskimos: are they caused by high dietary intake of eicosapentaenoic acid (EPA), a genetic variation of essential fatty acid (EFA) metabolism or a combination of both? / D.F. Horrobin // Med Hypotheses. – 1987. - V. 22. - N 4. - P. 421-428.

336.Hulley, S. Cholesterol in the elderly; is it important? / S. Hulley, T. Newman // JAMA. - 1994. - V. 272. - P. 13351340.

337.Hulley, S.B. Plasma higt-dencity lipoprotein cholesterol level. Influence of risk factor intervention / S.B. Hulley, R. Cohen, G. Widdowson //J.A.M.A. - 1977. - V. 238. - P. 2269-2271.

338.Hypertension and diabetes among Siberian Yupik Eskimos of St. Lawrence Island, Alaska / C.D. Schraer, S.O. Ebbesson, E. Boyko et al. // Public Health Rep.- 1996.- V. 111. - Suppl 2. - P. 51-52.

339.Hypertension in Alaska Native: association overweight, glucose intolerance, diet and mechanized activity / N.J. Murphy, C.D. Schraer, M.C. Theile et al. // Ethnicity & Health. -1997. - V. 2 - N 4. - P.267-275.

340.Hypertension prevalence and blood pressure levels in 6 EuropeanCountries, Canada, and the United States / K. Wolf-Maier, R.S. Cooper, J.R. Banegas et al. // JAMA. – 2003. – V. 289. – P. 2363-2369.

341.Implication of Recent Clinical Trials for the National Cholesterol Education Programm Adult Treatment Panel III Guidelines / S.M. Grundy, J.I. Cleeman, C.N. Bairey et al. // Circulation. - 2004. - V.110.- P.227-239.

342.Implications of guidelines for statin treatment for primary prevention of cardiovascular disease - risk factor analysis of the Scottish Health Survey 2003 / I. Haq, J. Hill, J. Craig et al. // Eur. Heart J. - 2007. - V. 28 (Abstract Suppl.). - P. 210-211.

343.Incidence of heart failure after myocardial infarction: Is it changing over time? /J.P. Hellerman, T. Y. Goraya, S. J. Jacobsen et al. // Arch. Int. Med.-1997. - V.157.- P.2413-2446.

344.Increased platelet aggregability associated with platelet GPIIIa PlA2 polymorphism: the Framingham Offspring Study / D. Feng, K. Lindpaintner, M.G. Larson et al. // Arterioscler. Thromb. Vasc. Biol. - 1999. - V. 19. - P. 1142–1147.

345.Indagine epidemiologica sulla prevalenza dell'ipertensione arteriosa nell'isola di Ponza / G. La Torre, I. Feola, E. De Vito, G. Ricciardi // Ann. Ig.: Med. Prev. e Comunitа.- 2001.- V.13, N 4.- P. 299-310

346.Induction of cyclin. A gene expression by homocysteine in vascular smooth muscle cells / J. Tsai, H. Wang, M. Perrella et al. // J. Clin. Invest. - 1996. – V.97. – P. 146—

- 206 -

153.

347.Infant feeding and adult glucose tolerance, lipid profile, blood pressure, and obesity / A.C. Ravelli, J.H. van der Meulen., C. Osmond et al. // Arch. Dis. Child. – 2000. – V. 82. - N 3. – P. 248– 52.

348.Inflammation biomarkers and near-term death in older men / N.S. Jenny, N.D. Yanez, B.M. Psaty et al. // Am. J. Epidemiol. 2007. – V. 165. - N 6. - P. 684-695.

349.Inflammatory, haemostatic, and rheological markers for incident peripheral arterial disease: Edinburgh Artery Study / I. Tzoulaki, G.D. Murray, A.J. Lee et al. // Eur. Heart. J. 2007. - V. 28. - N 3. - P. 354-362.

350.Inhibition of oxidation of human low density lipoprotein by phenolic substances in red wine/ E. M. Frankel, J. Ranner, J. B. German et al. // Lancet.- 1993.- V.341.- P.454457.

351.Joffe, M.M. Invited commentary: propensity scores / M.M. Joffe, P.R. Rosenbaum // Am. J. Epidemiol. - 1999. - V. 150. - P. 327-333.

352.Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. / A.V. Chobanian, G.L. Bakris, H.R. Black et al. // Hypertension. - 2003. - V. 42. - № 6. - P. 1206-1252.

353.Kannel W. B. Quest for an optimal population cardiovascular risk factor burden / W. B. Kannel // Eur. Heart J. - 2001. - V. 22. - P. 105-107.

354.Kannel W.B. Overview of hemostatic factors involved in atherosclerotic cardiovascular disease / W.B. Kannel // Lipids. – 2005. – V.40. - N 12. - P. 1215-1220.

355.Kannel, W. Some lesions in cardiovascular epidemiology from Fremingham / W. Kannel // Amer. Cardiol. - 1976. - V. 37. - P. 269-282.

356.Kannel, W.B. Blood pressure ahd risk of coronary heart disease: the Framingam study / W.B. Kannel, M.I. Schwartz, P.M. McNamara // Dis. Chest.-1969.-V.56.-P.43.

357.Kannel, W.B. Epidemiological assessment of the role of physical activity and fitness in development of cardiovascular disease / W.B. Kannel, P. Wilson, S. Blair // Am. Heart J. -1985. - V.109. - P.876-895.

358.Kannel, W.B. Range of serum cholesterol values in the population developing coronary artery disease / W.B. Kannel // Am. J. Cardiol.- 1995.- V.76.- P.69C–77C

359.Kannel, W.B. The Framingham study, section 30. Some characteristics related to the incidence of cardiovascular disease and death: 18-year Follow-up / W.B. Kannel, T. Gordon -Washington, 1974.

360.Kannel, W.В. Артериальное давление как фактор риска сердечно-сосудистых заболеваний / W.В. Kannel. // JAMA. - 1996. - V. 275. - N24. - P. 1571-1576.

361.Kaplan, G.A. Self - reports predictive of mortality frow ischemic heart disease: a nineyear folou-up of the Human Population Laboratory cogort / G.A. Kaplan, P.L. Kotler // J.Chron.Dis. - 1985. - V.38. - P.195-201.

362.Karasek, R.A. Healthy work. Basic Books / R.A. Karasek, T. Theorell. - New York, 1990. - 82 p.

363.Katon, W. Impact of major depression on chronic medical illness / W. Katon, P. Ciechanowski // J. Psychosom. Res.- 2002.- Vol.53.- P. 859-863.

364.Keys A. Alpha liprotein (HDL) cholesterol in the serum and the risk of coronary heart disease and death / A. Keys // Lancet. - 1980. - V.1. - P.603-606.

365.Keys, A. Coronary heart disease in seven countries A. Keys // Circulation. - 1970. - N 41. - P. 211.

366.Klatsky, A.L. Alcohol and mortality / A.L. Klatsky, M.A. Armstrong, G.D. Friedman //

- 207 -

Ann. Intern. Med. - 1992. - V. 117. - P. 646-654.

367.Klensch, H.Direct and indirect effects of nicotine on the arterial vascular system / H. Klensch // Z. Kardiol. – 1974. – V.63, N6. – P.494-510.

368.Komachi, Y., Natural experiment in cardiovascular diseases in Japan - morbidity trends of stroke and coronary heart disease and changes in their factors during the past two decades / Y. Komachi T. Shimamoto // X world congress of cardiol. - Washington, 1986. - P. 267.

369.Lloyd-Jones D.M. Lifetime risk of developing coronary heart disease / D.M. LloydJones, M.G. Larson, D. Levy // Lancet. - 1999. - V. 353. - P. 89-92.

370.Logistic model estimation of death attributable to risk factors for cardiovascular disease in Evans Country, Georgia / D.C. Deubner ,W.E. Wilkinson, M.J. Helms et al. //Am. J. Epidemiol. -1980. - V.112. - P.135-143.

371.Ludwig, D.S. Childhood Obesity - The Shape of Things to Come /D.S. Ludwig // N. Engl. J. Med. - 2007. - V. 357. - P.23-5.

372.Mahmud, A. Effect of smoking on arterial stiffness and pulse pressure amplification /A. Mahmud, J. Feely // J. Hypertension. - 2003. - V. 41. - P. 183.

373.Mancia G. Prevention and treatment of stroke in patients with hypertension / Mancia G. // Therapeutics. - 2004. - V. 26. - P. 631-648.

374.Manton, K. A comparison of risk factor on cardiovascular and total mortality in three studies / K. Manton, J.A. Dowd // Intern, conf. of preventive cardiol. - Moscow, 1985. - P. 34.

375.Marquez, P.V. Dying too young, addressing premature mortality and ill health due to non-communicable diseases and injuries in the Russian Federation (Summary). - 2005. - 147 p.

376.Meade T.W. Haemostatic function and ischaemic heart disease; principal results of the Northwick Park Heart Study / T.W. Meade, S. Mellows, M. Brozovic et al. // Lancet. – 1986. - N2. - P. 533 - 537.

377.Mental stress induces prolonged endotheiial dysfunction via endothelin-A receptors / L.E. Spieker, Е. Hurlimann, F. Ruschitzka et al. // Circulation. - 2002. - N5. - P. 7-20.

378.Moderate alcohol consumption and the risk of sudden cardiac death among U.S. male physicians / С.М. Albert, J.E. Manson, N.R. Cook et al. // Circulation. - 1999. - V.100. - P. 944.

379.Moderate alcohol intake and lower risk of coronary heart disease: Meta-analysis of effects on lipids and haemostatic factors / E.B. Rimm, P. Williams, K. Fosher et al. // BMJ. - 1999. – V. 319. – P.1523.

380.Moderate alcohol intake, increased levels of highdensity lipoprotein and its subfractions, and decreased risk of myocardial infarction / J.M. Gaziano, J.E. Buring, J.L. Breslow et al // N. Engl. J Med. – 1993. – V. 329. - P. 1829-1834.

381.No authors listed, JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice // Heart. - 2005. - V.91. - P. 1-52.

382.Novakovic, B. Occurrence of the metabolic syndrome in the population of the town of Novi Sad / B. Novakovic, M. Popovic // Med Pregl. - 2001. - V. 54, N1-2. - P.17-20.

383.Oakley, С. Aetiology, diagnosis, investigation, and management of the cardiomyopathies / С. Oakley // BMJ. -1997. - V.315. - P.1520-1524.

384.Obesity and Associated Coronary Heart Disease Risk Factors in a Population of LowIncome African-American and White Women: The North Carolina WISEWOMAN Project. / T.L. Nelson, K.J. Hunt, W.D. Rosamond et al. // Prev. Med. - 2002. – V. 35. - N 1. - P.1-6.

385.Obesity, hypertension, hyperurioemia and diabetes I mellitus among the Cree and Inuit of Notern Quebec / J.P. Thouez, J.M. Ekoe, P.M. Foggin et al. // Arct. Med. Res. -

- 208 -

1990.-V.49. - N.4. - P.180-188.

386.Onwuanyi, A.E. Cardiovascular disease mortality / A.E. Onwuanyi, A. Clarke, E. Vanderbush // J. Natl. Med. Assoc. - 2003. – V. 95. - N 12. - P. 1146-1151.

387.Opadijo O.G. Prevalence of coronary heart disease risk factors in Nigerians with systemic hypertension / O.G. Opadijo, A.A. Akande, A.K. Jimoh // Afr. J. Med. Sci.- 2004.- V. 33.- N 2.- P. 121-125.

388.Optimal risk factors in the population: prognosis, prevalence and secular trends. Data from Gote-borg population stadies / A. Rosengren, A. Dotevall, H. Eriksson, L. Wilhelmsen // Eur. Heart J. - 2001. - V. 22. - P. 136-144.

389.Oram, S. Smocing and ischaemic heart disease / S. Oram //Brit. Heart J.-1968. - V.30. - P.145-152.

390.Orth-Gomer, K. Social network interaction and mortality a six-year follow-up study of a random sample of the Swedish population / K. Orth-Gomer // Council on Epidemiol. Amer. Heart Assoc. - 1985. - N 38. - P. 48.

391.Paseng, W.P. Outcome of untreated hypertensives in an agricultural population, a 20 year follow-up / W.P. Paseng // X world congress of cardiology. - Washington, 1986. - P. 266.

392.Petitti, D.B. Risk of vascular disease in women. Smoking, oral contraceptives, noncontraceptive estrogens, and other factors / D.B. Petitti, J. Wingerd, F. Pellegrin, et al. // J.A.M.A.-1979. - V.242. - P.1150-1154.

393.Pitt, В. Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events. Prospective Randomized Evaluation of the Vascular Effects of Norvasc Trial (PREVENT) / B. Pitt., R. Byington, C. Furberg et al. // Circulation. - 2000. - V. 102. - P. 1503-1510.

394.Plasma fibrinogen levels and their correlates in 6457 coronary heart disease patients. The Bezafibrate Infarction Prevention (BIP) Study / E. Barasch, M. Benderly, E. Graff et al. // J. Clin. Epidemiol. - 1995. - V. - 48. - P. 757 - 765.

395.Pleiotropic effects of statins: benefit beyond cholesterol reduction? A meta-regression analysis // J.G.Robinson, B. Smith, N. Maheshwari et al. // J. Am. Coll. Cardiol. - 2005.- V. 46. - P.1855—1862.

396.Poland-US Collaborative Study in CVD Epidemiology: CHD Risk Factors Profiles for Categories of European Atherosclerosis Society (EAS) / J. Sznajd, S. Rywik, D. Williams et al. // Guidelines for hypertension: International Conference, 2-nd. - Washington, 1989. - P. A-27.

397.Polymorphisms of platelet membrane glycoprotein Ibα associated with arterial thrombotic disease / R. Gonzalez-Conejero, M. Lozano, J. Rivera et al. // Blood. - 1998. - V. 92. - P. 2771–2776.

398.Polymorphisms of the angiotensin-converting-enzyme gene in subjects who die from coronary heart disease / A.E. Evans, O. Poirier, F. Kee et al. // Q. J. Med. – 1994. – V. 87. – P. 211-214.

399.Population-based distributions of haemostatic variables / T.W. Meade, W.R. North, R. Chakrabarti et al. // Br. Med. Bull. – 1977. - V. 33. - P. 283 -288.

400.Puska, P. Epidemiology of coronary heart disease and its risk indicators in South-West and East Finland / P. Puska, M. Rimpela // Nordic Council for Arctic Medical Research report. – 1994. – N7. – P. 21–26.

401.Puska, P. Succesful strategies to influence national diets: the Finnish experience / P.Puska // Zdrav. – 2003. – V. 43. - P.191-196.

402.Racial and ethnic disparities in cardiovascular risk factors among stroke survivors: United States 1999 to 2001. / H.F. McGruder, A.M. Malarcher, T.L. Antoine et al. // Stroke. - 2004. – V. 35. - N 7. - P.1557-1561.

- 209 -